Augmented Care at Worksite for Diabetes Prevention

Impact of Augmented Care at the Worksite for Diabetes Prevention

Sponsors

Lead Sponsor: Ohio State University

Source Ohio State University
Brief Summary

The purpose of the study is to evaluate the impact of augmented care at the worksite through a lifestyle intervention for diabetes prevention among employees with prediabetes who are slower to respond to a standard diabetes prevention intervention.

Detailed Description

Employees at The Ohio State University (OSU) with prediabetes will participate in a standard lifestyle intervention for diabetes prevention. Participants who do not achieve >2.5% weight loss by week 5 of the intervention will transition into augmented care with an enhanced training program that addresses values clarification, decision making, planning, and problem solving. The impact of the enhanced intervention will be evaluated at 4, 12 and 18 months from baseline to determine if implementing early enhanced training helps participants achieve and maintain weight loss similar to those who received the standard intervention.

Overall Status Recruiting
Start Date 2018-02-08
Completion Date 2023-12-01
Primary Completion Date 2023-06-01
Phase N/A
Study Type Interventional
Primary Outcome
Measure Time Frame
Weight loss Weight will be taken at baseline, 4 months (mos), 12 months, and 18 months
Secondary Outcome
Measure Time Frame
Decreased Glycemia Glucose will be taken at baseline, 4 mos, 12 mos, and 18 mos.
Enrollment 236
Condition
Intervention

Intervention Type: Behavioral

Intervention Name: Group Lifestyle Balance (GLB)

Description: The intervention includes the following key features: 1) individual case managers or "lifestyle coaches;" 2) frequent contact with participants; 3) a structured, state-of-the-art, 16-session core-curriculum that teaches behavioral self-management strategies for weight loss and physical activity; 4) a more flexible maintenance intervention, combining group and individual approaches and motivational campaigns; 6) individualization through a "toolbox" of adherence strategies; and 7) tailoring of materials and strategies utilizing a network of training, feedback, and support.

Arm Group Label: Group Lifestyle Balance (GLB)

Intervention Type: Behavioral

Intervention Name: Group Lifestyle Balance Plus (GLB+)

Description: The GLB+ intervention arm will include participants who did not achieve the targeted percentage of weight loss by week 5, and will add enhanced training to the program that will focus on values clarification, mindful decision making, planning, and problem solving.

Arm Group Label: Group Lifestyle Balance Plus (GLB+)

Eligibility

Criteria:

Inclusion Criteria: 1. Benefits-eligible Ohio State University employee 2. Intend to be employed by OSU through the length of the follow-up phase 3. Body mass index: >24 kg/m2 non-Asians; >22 kg/m2 Asians 4. American Diabetes Association risk score of ≥ 5 5. Fasting blood glucose of 100-125 mg/dL 6. Blood glucose of 110-199 (if non-fasting in previous 2 hours) Exclusion Criteria: 1. Blood glucose level of ≥ 200 mg/dL 2. Conditions that would limit adoption of light/moderate physical activity (i.e., cardiac event, severe chronic obstructive pulmonary disease, advanced arthritis, poorly controlled hypertension) 3. Chronic use of medications that affect blood glucose levels (i.e., corticosteroids) 4. Concurrent participation in a structured weight loss program or counseling for bariatric surgery 5. Pregnant or breastfeeding 6. Score of ≥ 10 on the Patient Health Questionnaire-8 indicating moderate to severe depressive symptoms 7. Score of ≥ 27 on the Binge Eating Scale 8. Unwilling to accept randomization 9. Planning to move from the area or changing employment.

Gender:

All

Minimum Age:

21 Years

Maximum Age:

N/A

Healthy Volunteers:

No

Overall Official
Last Name Role Affiliation
Carla Miller, Ph.D. Principal Investigator Ohio State University
Overall Contact

Last Name: Carla Miller, Ph.D.

Phone: 614-292-1391

Email: [email protected]

Location
Facility: Status: Contact: The Ohio State University Carla Miller, Ph.D. 614-292-1391
Location Countries

United States

Verification Date

2021-02-01

Responsible Party

Type: Principal Investigator

Investigator Affiliation: Ohio State University

Investigator Full Name: Carla Miller

Investigator Title: Professor

Keywords
Has Expanded Access No
Condition Browse
Number Of Arms 2
Arm Group

Label: Group Lifestyle Balance (GLB)

Type: Active Comparator

Description: Implement the first 4-sessions of the core 16-session phase of the GLB intervention for diabetes prevention to all participants. Determine percent weight change at week 5. Those who achieve >2.5% weight loss at week 5 will remain in the GLB arm.

Label: Group Lifestyle Balance Plus (GLB+)

Type: Experimental

Description: Implement the first 4-sessions of the core 16-session phase of the GLB intervention for diabetes prevention to all participants. Determine percent weight change at week 5. Those who fail to achieve >2.5% weight loss at week 5 will transfer to the GLB+ arm.

Patient Data Yes
Study Design Info

Allocation: Randomized

Intervention Model: Parallel Assignment

Intervention Model Description: The proposed translational study applies an innovative experimental approach, an adaptive design, to optimize treatment for weight loss and weight loss maintenance in individuals with prediabetes. All participants will begin a standard lifestyle intervention to promote weight loss. Those who do not achieve >2.5% weight loss during the first month of the intervention will transition to augmented care to enhance weight loss during the intensive intervention phase. Following the intensive phase, participants will be randomly assigned to either the standard intervention or the enhanced intervention for the maintenance study phase. By randomly assigning participants to either the standard maintenance phase of the intervention or the innovative maintenance phase of the intervention following the initial core phase, the impact of extended training in self-regulation for weight loss maintenance will be evaluated.

Primary Purpose: Prevention

Masking: Single (Outcomes Assessor)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact [email protected]. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on PreDiabetes

Clinical Trials on Group Lifestyle Balance (GLB)